NASDAQ · Financial Statements

Coeptis Therapeutics Holdings, Inc. (COEP) Financial Statements

$10.99 NASDAQ: COEP Market Cap $38.62M

Coeptis Therapeutics Holdings, Inc. most recently reported annual revenue of $1.0M, net profit of $-12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-14.0M$-34.0M$-21.0M$-10.0M$-13.0M
Net Profit$-13.0M$-38.0M$-21.0M$-11.0M$-12.0M
EPS$-13.16$-2.87$-0.83$-5.65$-2.81
Op Margin-18727.9%———-956.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$7.0M$8.0M$8.0M$9.0M$20.0M
Total Liabilities$4.0M$3.0M$4.0M$5.0M$2.0M
Cash$2.0M$4.0M$1.0M$1.0M$6.0M
Borrowings$4.0M$2.0M$1.0M$1.0M$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-4.0M$-7.0M$-7.0M$-9.0M
Investing Cash Flow$-3.0M$0$0$0$0
Financing Cash Flow$0$5.0M$0$1.0M$0
Net Cash Flow$2.0M$2.0M$-2.0M$-1.0M$5.0M
Free Cash Flow$-6.0M$-4.0M$-7.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-3.10
FCF Yield-20.71%
Quick Ratio3.25
Interest Coverage-22.39
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
COEP Overview COEP Dividend Run Stock Screener